Compass Therapeutics, Inc. (CMPX) Dividend History

Compass Therapeutics, Inc. is a biotechnology company focused on developing innovative immunotherapies for cancer and other diseases. The company utilizes proprietary platform technologies to discover and develop monoclonal antibodies and other biologics aimed at modulating the immune system to combat chronic diseases.

80 Guest Street, Boston, MA, 02135
Phone: 617-500-8099
Website:

Dividend History

Compass Therapeutics, Inc. currently does not pay dividends

Company News

  • Top 3 High-Momentum Companies Analysts Are Still Bullish On

    Three companies with recent stock rallies that analysts remain bullish on are Compass Therapeutics, Amprius Technologies, and Allot Communications. Analysts see significant upside potential in these momentum stocks despite their recent gains.

    Investing.com
    Featured Companies: ALLT AMPX
  • Compass Therapeutics to Participate in Upcoming Investor Events

    Compass Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in two investor conferences in September 2024, where it will present updates on its oncology-focused pipeline of antibody-based therapeutics.

    GlobeNewswire Inc.
  • Eliem Therapeutics Announces Additions to its Leadership Team

    Eliem Therapeutics announced the appointments of Brett Kaplan, M.D., as Chief Operating Officer, and Nishi Rampal, M.D., as Senior Vice President, Clinical Development. The new executives bring extensive experience in the pharmaceutical and biotechnology industries, which will help Eliem advance its pipeline of therapeutics for autoimmune-driven inflammatory diseases.

    GlobeNewswire Inc.
  • Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference

    Compass Therapeutics, a clinical-stage biopharmaceutical company, announced that it will present at the Wedbush PacGrow Healthcare Conference on August 13, 2024. The company is developing proprietary antibody-based therapeutics to treat multiple human diseases, with a focus on the relationship between angiogenesis, the immune system, and tumor growth.

    GlobeNewswire Inc.
  • Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference

    BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place in New York City, NY June 5 – 6, 2024.

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 05:11:10 UTC